Drug Development

Articles

Sigma-Aldrich's custom manufacturing services business unit, SAFC, has launched a new protein quality supplement for biological drug production, including biosimilars.

SAFC Introduces New Protein Quality Supplement for Optimized Biologics Production

Bristol-Myers Squibb announced that they have reached an agreement with F-star Alpha, giving BMS the exclusive option to acquire F-star's HER2-targeted breast and gastric cancer treatment.

Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

The divestment will create the number two player in the global influenza vaccine industry.

Novartis Sells Influenza Vaccine Business to CSL for $275 Million

GSK's investigational Ebola vaccine is in Phase I safety trials.

GSK Accelerates Ebola Vaccine Development

Johnson& Johnson is collaborating with WHO and others on clinical testing, development, production, and distribution of an Ebola vaccine.

J&J Speeds Ebola Vaccine Development and Expands Production

The agency recommends that companies developing drugs to treat Ebola apply for orphan drug designation.

EMA Works to Speed Up Ebola Treatment

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Manufacturers using highly potent APIs must examine cross-contamination routes and determine acceptable limits.

Evaluating Cross-Contamination Risk of Highly Potent APIs

IDT Biologika completes large-scale biologics finishing facility in Dessau, Germany.

IDT Biologika Certifies Facility to Fill and Lyophilize Biologics and Vaccines

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

The total market for biopharmaceuticals in 2013 was $36.8 billion according to Kalorama Information. Meanwhile, Frost & Sullivan estimates that the biosimilars market, which it pegged at just $1.2 billion in 2013, will grow to $23 billion in 2019, or more than 20-fold increase.

Focus on Biosimilars

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Pharmaceutical Technology Europe spoke with Piero Iamartino, R&D director at Micro-Macinazione, about the role of micronization in pharmaceutical manufacturing.

Formulation and Drug Delivery